Evaluation of Methicillin Resistant Staphylococcus aureus (MRSA)

• Research type

  Research Study

• Full title

  Quantitative evaluation of Methicillin Resistant Staphylococcus aureus (MRSA) during routine nasal decolonisation programmes with Bactroban Nasal [Intervention Review] Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization

• IRAS ID

  47154

• Contact name

  Peter Riley

• Sponsor organisation

  St George's Healthcare NHS Trust

• Eudract number

  2010-020206-14

• ISRCTN Number

  n/a

• Research summary

  200 patients admitted into the hospita and diagnosed with MRSA having been commenced on Bactroban nasal ointment will be recruited into the study. When they have completed their treatment, a urine sample will be taken to assess objectively their adherence and a questionnaire will be completed by the patient to obtain subjective data with adherence. Nasal swabs will be taken from the patients 2 weeks after treatment, then 1,2,3,4 and 6 months later to assess decolonisation and relapse rate. A selection of patients will be interviewed after 6 months to review comments to the questionnaire.

• REC name

  London - Surrey Borders Research Ethics Committee

• REC reference

  10/H0806/84

• Date of REC Opinion

  31 Jan 2011

• REC opinion

  Further Information Favourable Opinion